BsUFA III Talks Begin With Regulatory Science Disagreement

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background
Negotiations to extend BsUFA another five years began in March. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics